EGFR and non-small cell lung carcinoma: The ROC curves were used to evaluate the predictive prognostic power of risk score, and the results indicated that risk score could simultaneously predict OS, PFS, and EGFR-TKI response in NSCLC patients, which was consistent with the results of the survival curves (P < 0.05; Figure S4J, S5J, and S6J).